- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.60 Å
- Oligo State
- homo-dimer
- Ligands
- 6 x MG: MAGNESIUM ION(Non-covalent)
- 2 x IPE: 3-METHYLBUT-3-ENYL TRIHYDROGEN DIPHOSPHATE(Non-covalent)
IPE.4: 12 residues within 4Å:- Chain A: G.53, K.54, R.57, Q.93, R.109, R.110, T.198, Y.201, F.236, Q.237, D.240
- Ligands: ZOL.5
15 PLIP interactions:15 interactions with chain A- Hydrophobic interactions: A:T.198, A:F.236, A:D.240
- Hydrogen bonds: A:K.54, A:Q.93
- Water bridges: A:Y.55, A:R.109, A:K.254, A:R.348
- Salt bridges: A:K.54, A:K.54, A:R.57, A:R.57, A:R.110, A:K.254
IPE.9: 12 residues within 4Å:- Chain B: G.53, K.54, R.57, Q.93, R.109, R.110, T.198, Y.201, F.236, Q.237, D.240
- Ligands: ZOL.10
16 PLIP interactions:16 interactions with chain B- Hydrophobic interactions: B:T.198, B:F.236, B:D.240
- Hydrogen bonds: B:K.54, B:Q.93
- Water bridges: B:Y.55, B:R.109, B:K.254, B:R.348, B:K.350
- Salt bridges: B:K.54, B:K.54, B:R.57, B:R.57, B:R.110, B:K.254
- 2 x ZOL: ZOLEDRONIC ACID(Non-covalent)
ZOL.5: 15 residues within 4Å:- Chain A: L.97, D.100, D.104, R.109, Q.168, K.197, T.198, Y.201, Q.237, D.240, K.254
- Ligands: MG.1, MG.2, MG.3, IPE.4
10 PLIP interactions:10 interactions with chain A- Hydrogen bonds: A:R.109, A:R.109, A:Q.237, A:D.240
- Water bridges: A:D.101, A:S.106, A:Q.168, A:K.197, A:K.197
- pi-Cation interactions: A:K.197
ZOL.10: 15 residues within 4Å:- Chain B: L.97, D.100, D.104, R.109, Q.168, K.197, T.198, Y.201, Q.237, D.240, K.254
- Ligands: MG.6, MG.7, MG.8, IPE.9
16 PLIP interactions:16 interactions with chain B- Hydrogen bonds: B:D.100, B:R.109, B:R.109, B:Q.237, B:D.240
- Water bridges: B:D.104, B:D.104, B:D.104, B:S.106, B:Q.168, B:K.197, B:K.197, B:D.244, B:D.244, B:D.244
- pi-Cation interactions: B:K.197
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rondeau, J.M. et al., Structural basis for the exceptional in vivo efficacy of bisphosphonate drugs. Chemmedchem (2006)
- Release Date
- 2006-02-28
- Peptides
- Farnesyl Diphosphate Synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
FB
F
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.60 Å
- Oligo State
- homo-dimer
- Ligands
- 6 x MG: MAGNESIUM ION(Non-covalent)
- 2 x IPE: 3-METHYLBUT-3-ENYL TRIHYDROGEN DIPHOSPHATE(Non-covalent)
- 2 x ZOL: ZOLEDRONIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rondeau, J.M. et al., Structural basis for the exceptional in vivo efficacy of bisphosphonate drugs. Chemmedchem (2006)
- Release Date
- 2006-02-28
- Peptides
- Farnesyl Diphosphate Synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
FB
F